Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Revive Therapeutics Ltd. (V.RVV) had Return on Tangible Equity of -231.56% for the most recently reported fiscal quarter, ending 2022-03-31.
| Income Statement Financials | |
-- |
|
-4.75M |
|
-- |
|
-- |
|
-- |
|
-4.75M |
|
-- |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
-4.75M |
|
320.11M |
|
320.11M |
|
-0.02 |
|
-0.02 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.55M |
|
-- |
|
-- |
|
-- |
|
2.63M |
|
11.92M |
|
2.05M |
|
11.92M |
|
320.68M |
|
| Cash Flow Statement Financials | |
-9.10M |
|
-- |
|
0.16M |
|
13.10M |
|
4.17M |
|
-8.93M |
|
0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.83 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.10M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.88% |
|
|
Return on Tangible Equity |
-231.56% |
-32.67% |
|
-39.24% |
|
0.05 |
|
-0.03 |
|
-0.03 |
|